08 Drugs for eye and skin conditions Flashcards

1
Q

8.01 GLAUCOMA EYEDROPS

Muscarinic agonists - pilocarpine

A

from the opposing end, antimuscarinic eye drops can worsen glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

8.01 GLAUCOMA EYEDROPS

Prostaglandin F2 analogues - latanoprost, bimatoprost

A

increases outflow of aqueous humour to reduce intraocular pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

8.01 GLAUCOMA EYEDROPS

Adrenergic agonists and antagonists - brimonidine, timolol

A

reduction in intraocular pressure can be achieved with α2-adrenergic agonists (brimonidine) or β-adrenergic antagonists (timolol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

8.01 GLAUCOMA EYEDROPS

Carbonic anhydrase inhibitors - dorzolamide

A

decreases aqueous humour production
acetazolamide oral formulation is used as a diuretic and for mountain sickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

8.02 VEGF INHIBITORS

Ranibizumab, aflibercept, bevacizumab - actions

A

reduces vasculogenesis and angiogenesis
decreases new vessel formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

8.02 VEGF INHIBITORS

Ranibizumab, aflibercept, bevacizumab - MOA

A

inhibits vascular endothelial growth factor (VEGF), which is responsible for maintenance of vasculature and new vessel formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

8.02 VEGF INHIBITORS

Ranibizumab, aflibercept, bevacizumab - abs/distrib/elim

A

given as intravitreal injections for neovascular pathology in the retina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

8.02 VEGF INHIBITORS

Ranibizumab, aflibercept, bevacizumab - clinical use

A

wet age-related macular degeneration
thrombosis of retinal vasculature
diabetic retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

8.02 VEGF INHIBITORS

Ranibizumab, aflibercept, bevacizumab - adverse effects

A

local ophthalmic complications from intravitreal injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

8.03 RETINOIDS

Vitamin A derivatives: isotretinoin, adapalene, acitretin, tretinoin - actions

A

attenuate proliferative and inflammatory response
reduce sebaceous gland production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

8.03 RETINOIDS

Vitamin A derivatives: isotretinoin, adapalene, acitretin, tretinoin - MOA

A

bind to RXR (retinoid X receptor) and RAR (retinoic acid receptor) nuclear receptors to modulate epidermal cell growth and sebaceous gland activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

8.03 RETINOIDS

Vitamin A derivatives: isotretinoin, adapalene, acitretin, tretinoin - abs/distrib/elim

A

given orally, variable bioavailability
topical tretinoin and adapalene for acne
large proportion bound to plasma proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

8.03 RETINOIDS

Vitamin A derivatives: isotretinoin, adapalene, acitretin, tretinoin - clinical use

A

acne (isotretinoin, adapalene)
psoriasis (acitretin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

8.03 RETINOIDS

Vitamin A derivatives: isotretinoin, adapalene, acitretin, tretinoin - adverse effects

A

major risk of teratogenicity - restricted use and close monitoring is required
hypervitaminosis A - dry or inflamed mucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

8.04 TREATMENT OF PSORIASIS

Retinoids e.g. acitretin, alitretinoin

A

normalises epidermal cell differentiation and keratinisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

8.04 TREATMENT OF PSORIASIS

Vitamin D analogues e.g. calcipotriol

A

applied topically to promote differentiation and suppress proliferation of keratinocytes

17
Q

8.04 TREATMENT OF PSORIASIS

Dithranol

A

mode of action unclear, but typically used in short-contact therapy where topical application is washed off after 1h

18
Q

8.04 TREATMENT OF PSORIASIS

Apremilast

A

anti-inflammatory effect through inhibition of phosphodiesterase 4

19
Q

8.04 TREATMENT OF PSORIASIS

Dimethyl fumarate

A

immunomodulatory effect
used in moderate to severe plaque psoriasis

20
Q

8.04 TREATMENT OF PSORIASIS

Monoclonal antibodies

A

diverse range of biopharmaceuticals used in psoriasis
e.g. adalimumab, ustekinumab, secukinumab

21
Q

8.05 SKIN PARASITES

Permethrin

A

single application
to be washed off 8-12h later
for treatment of scabies

22
Q

8.05 SKIN PARASITES

Crotamiton

A

applied once daily for 3-5 days
for treatment of scabies
can also be used for pruritus due to chickenpox, dermatitis, etc.

23
Q

8.05 SKIN PARASITES

Dimeticone

A

used for head lice
topical application to hair
washed off after 8h